964 results on '"Dang, Chi V."'
Search Results
2. ACLY alternative splicing correlates with cancer phenotypes
3. Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
4. Targeting cancer metabolism in the era of precision oncology
5. Time to hit pause on mitochondria-targeting cancer therapies
6. Hypermetabolic state is associated with circadian rhythm disruption in mouse and human cancer cells.
7. Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
8. Tilting MYC toward cancer cell death
9. Drugging the 'undruggable' cancer targets
10. MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
11. Hypermetabolic state is associated with circadian rhythm disruption in mouse and human cancer cells
12. Pathways Involved in the Effect of Eflornithine in Neuroblastoma
13. Measuring MYC-Mediated Metabolism in Tumorigenesis
14. The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
15. Pathways Involved in the Effect of Eflornithine in Neuroblastoma.
16. MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis
17. Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus
18. Feeding frenzy for cancer cells
19. Warburg Effect
20. MYC-induced metabolic stress and tumorigenesis
21. Role of NADPH Oxidase in Arsenic-Induced Reactive Oxygen Species Formation and Cytotoxicity in Myeloid Leukemia Cells
22. Data from Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells
23. Supplementary Figures 1-5, Tables 1-2 from Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells
24. Unique Conformation of Cancer Autoantigen B23 in Hepatoma: A Mechanism for Specificity in the Autoimmune Response
25. A Strategy for Identifying Transcription Factor Binding Sites Reveals Two Classes of Genomic c-Myc Target Sites
26. MYC, Metabolic Synthetic Lethality, and Cancer
27. The c-Myc Target Gene PRDX3 is Required for Mitochondrial Homeostasis and Neoplastic Transformation
28. Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism
29. Induction of Ribosomal Genes and Hepatocyte Hypertrophy by Adenovirus-Mediated Expression of C-Myc in vivo
30. Identification of CDK4 as a Target of c-MYC
31. IREI[alpha] RNase-dependent lipid homeostasis promotes survival in Myc- transformed cancers
32. MYC Regulation of Metabolism and Cancer
33. Identification of a Large Myc-Binding Protein that Contains RCC1-Like Repeats
34. A Unique Glucose-Dependent Apoptotic Pathway Induced by c-Myc
35. A PERK–miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival
36. Nuclear Punctate Distribution of ALL-1 is Conferred by Distinct Elements at the N Terminus of the Protein
37. c-Myc Transactivation of LDH-A: Implications for Tumor Metabolism and Growth
38. Supplementary Data from Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer
39. Supplemental Table S5 from MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels
40. Data from MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels
41. Supplemental Figures 1 to 4 from MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels
42. Data from Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer
43. Supplementary Table from Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer
44. Supplementary Figure from Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer
45. SF1-4 from Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
46. Supplementary methods and figures S1-S8 from Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
47. Supplemental table description and figure legends from MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels
48. Supplementary Methods from Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
49. Data from Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
50. Supplementary Figure 7 from Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.